Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Clears Plan For State-Level Drug Buys, Free Pills For Some Patients

This article was originally published in PharmAsia News

Executive Summary

India Health Minister Ghulam Nabi Azad gave final clearance to a national plan to allow states more freedom to buy drugs for the hospitals they run and to provide some for free to certain patients, such as pregnant women.

India Health Minister Ghulam Nabi Azad gave final clearance to a national plan to allow states more freedom to buy drugs for the hospitals they run and to provide some for free to certain patients, such as pregnant women. The states would be required to conduct an open tender for drug supplies from firms with good-manufacturing practices certificates, with the medicines supplied labeled not for resale. The plan would increase funding to the National Rural Health Mission by $240 million. (Click here for more)

"Free Medicines Scheme Gets 1,300 Crore Rupees Boost" - Times Of India (9/20/2012)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC082220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel